News
Aetion President Kevin Riley Discusses the Future of Real-World Evidence with Nasdaq at HLTH USA
Aetion President Kevin Riley joined Nasdaq’s Kristina Ayanian at HLTH USA to discuss how ...
News
Aetion Announces Leadership Changes
Kevin Riley, industry leader with global experience in technology commercialization, ...
News
Intuitive Announces FDA Clearance of Revised da Vinci Xi and X Labeling on Radical Prostatectomy
Intuitive announced FDA clearance for a labeling revision of its da Vinci X and Xi ...
News
Aetion Launches Barcelona Technology Hub and Appoints Ken Watson as Chief Technology Officer
BARCELONA, SPAIN, June 25, 2024—Aetion®, the global leader in real-world evidence (RWE) ...
News
Prophecy Enables Aetion to Quickly Deliver Critical Healthcare Data Analytics
Aetion leveraged Prophecy's AI-powered data transformation platform to deploy its ...
News
xCures and Aetion® Further Enhance Partnership with Rich Real-World Datasets
Aetion and xCures have expanded their partnership, enabling access to five comprehensive ...
News
COTA and Aetion partner to expand access to real-world data for oncology research
At the heart of every oncology breakthrough is trustworthy data. Researchers rely on ...
News
xCures to Contribute Data to Support Aetion®’s Collaboration with FDA
In a step forward for healthcare research, xCures is pleased to announce that it will ...
News
Health equity should start at birth
Medcitynews in 2022 reports that pregnant women and others able to give birth are ...
News
Using real-world evidence to advance COVID-19 medical countermeasures
The project focuses on rapidly assessing the safety and effectiveness of COVID-19 ...
News
Aetion acquires Replica Analytics to bring aboard synthetic data capabilities
Health analytics firm Aetion has acquired Replica Analytics, a company that specializes ...
News
Real-world evidence firm Aetion grabs privacy-protected synthetic data provider Replica Analytics
Aetion, which provides real-world evidence and analytics to drug companies, payers, life ...
News
Aetion snaps up AI health data specialist Replica Analytics
Aetion's acquisition of artificial intelligence data specialist Replica Analytics gives ...
News
Aetion acquires synthetic data platform Replica Analytics
This acquisition allows Aetion to solve for one of the toughest problems in RWE: access ...
News
Aetion snaps up synthetic real-world data company Replica Analytics
Less than a year after Aetion landed $110 Million in Series C funding, Aetion acquires ...
News
FDA, Aetion expand RWE work to focus on inpatient COVID-19 therapies
FDA and Aetion announced they will use the Aetion Evidence Platform® to gather real-world ...
News
How to collect and submit RWD to win approval for a new drug indication: FDA spells it out in a long-awaited guidance
EndPoints News reports in 2021 that real-world data are messy. There can be differences ...
News
FDA contracts Aetion’s real-world evidence platform to assess COVID-19 treatments
The Food and Drug Administration has contracted with real-world evidence company Aetion ...
News
Real-world evidence: 'Labor-intensive' data standardization may be required by US FDA
New draft guidance offers recommendations for translating real-world data from claims or ...
News
Heard at HLTH: Can we get Ironman’s J.A.R.V.I.S. in the world of drug development?
MedCity News 2021 writes that at the recent HLTH conference, a panel discussed the role ...
News
FDA adcomm votes unanimously in support of a J&J Covid-19 booster two months after one-dose shot
The FDA's Vaccines and Related Biological Products Advisory Committee (VRBPAC) ...
News
England’s NICE starts work to develop RWE standards
NICE collaborates with Aetion to leverage real-world evidence studies to address evidence ...
News
Aetion to collaborate with UK's NICE on RWE
New York-based real-world evidence (RWE) firm Aetion is partnering with the National ...
News
Industry Voices—COVID-19 vaccine rollout shows real-world evidence was ready for the spotlight
The incredibly fast development and rollout of the vaccines would not have been possible ...